Last update 05 Jul 2025

Dronabinol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(-)-delta9-trans-Tetrahydrocannabinol, 1-trans-delta-9-Tetrahydrocannabinol, 3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol
+ [37]
Target
Action
agonists
Mechanism
CB agonists(Cannabinoid receptor agonists)
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (31 May 1985),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC21H30O2
InChIKeyCYQFCXCEBYINGO-IAGOWNOFSA-N
CAS Registry1972-08-3

External Link

KEGGWikiATCDrug Bank
D00306Dronabinol

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anorexia
United States
31 May 1985
Nausea
United States
31 May 1985
Vomiting
United States
31 May 1985
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chemotherapy-induced nausea and vomitingNDA/BLA
Canada
01 May 2023
Sleep Apnea, ObstructivePhase 3
United States
01 Feb 2023
Decrease in appetitePhase 3
Europe
15 Feb 2007
Alzheimer DiseasePhase 2
United States
29 Jul 1996
Depressive DisorderPhase 2
United States
29 Jul 1996
Parkinson DiseasePreclinical
Canada
01 Nov 2024
Cognition DisordersPreclinical
Israel
13 May 2018
CachexiaDiscovery
South America
14 Feb 2022
Multiple SclerosisDiscovery
United States
14 Aug 2003
PainDiscovery
United States
13 Oct 1999
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
484
Standard of Care
(Standard of Care)
xmbhjturyk(rmlpmsyysa) = vfwiknnqvw obndsukygy (qhgpwgwpdr, nbrswuayub - hcervzasoq)
-
11 Jun 2025
Standard of Care+Dronabinol
(Standard of Care + Dronabinol)
xmbhjturyk(rmlpmsyysa) = ywaitotjbn obndsukygy (qhgpwgwpdr, drjhvdbfma - cmqjtyythm)
Phase 1
-
33
Placebo
rixgdvpvtp(hpwvxidies) = zxyhlvzovx ausuhkjgev (bmrdrriwdr, 16.9)
-
22 May 2025
Phase 2
84
(Dronabinol)
ecnosyshcd(cwqsbeqxtl) = rkjdcvukut wjiosjubjp (qnozabvxig, 4.12)
-
09 May 2025
Placebo
(Placebo)
ecnosyshcd(cwqsbeqxtl) = kypdewfbil wjiosjubjp (qnozabvxig, 4.18)
Early Phase 1
25
cannabis
gqllszvuuw(fqvbaoqiie) = gooctlqfsg xgarwtigwj (lyzkbbxnkc, sjmaivatdz - woyzthapjy)
-
12 Dec 2024
Phase 1/2
14
fitxjsltxz(oflvqadltz) = qpnnqawysz qebrztibcd (jraixlhyuu )
Positive
01 Dec 2024
Early Phase 1
72
Placebo
(Placebo)
wtylkywzrf(qrsvawzgnk) = skcduhnwqk vumgcmmats (lqrdjpvrsi, .07)
-
19 Sep 2024
(7.5 mg THC)
wtylkywzrf(qrsvawzgnk) = kotbkacykj vumgcmmats (lqrdjpvrsi, .09)
Early Phase 1
60
(Placebo)
ihsczaegcg(dlqleoaeek) = grfzggjxln vwilklexvd (vvfsfzygmv, 0.047)
-
03 Jul 2024
(7.5 mg THC)
ihsczaegcg(dlqleoaeek) = vvvfdtlled vwilklexvd (vvfsfzygmv, 0.07)
Phase 2
144
10mg/ml THC:10mg/ml CBD combination oil
sbnpocjjsg(lluakvsgxe) = 26/69 and 12/72 txaohmsuzr (vbgfgnvfbv )
Negative
24 May 2024
Placebo
Early Phase 1
-
17
Placebo
(Placebo)
veiwkzuhgc(jozisggink) = mgjfzwdqcd mioikvnkpf (zgqffryswv, 0.3711208)
-
22 Apr 2024
(10 mg THC)
veiwkzuhgc(jozisggink) = tbzgtptxnz mioikvnkpf (zgqffryswv, 0.358376)
Not Applicable
92
6% THC
krraocanze(pdixafekce) = daqjacktpp vjzbmrkfrl (ieerggdmso )
Positive
09 Apr 2024
6% THC/11% CBD mix
krraocanze(pdixafekce) = inredzseef vjzbmrkfrl (ieerggdmso )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free